Multiple Adverse Histological Features Increase the Odds of Under Staging T1 Bladder Cancer

Alon Z. Weizer, Matthew J. Wasco, Rou Wang, Stephanie Daignault, Cheryl T. Lee, Rajal B. Shah

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Purpose: The clinical under staging of T1 bladder cancer potentially delays therapy and undermines survival. In this study we evaluated clinicopathological features to aid in the identification of patients with clinical T1 bladder cancer at risk for under staging. Materials and Methods: We identified patients diagnosed with clinical T1 bladder cancer who underwent cystectomy within 4 months. Muscularis propria was present and uninvolved in initial biopsies or patients had a re-staging biopsy with muscle invasion present. Under staging was defined as pT2 or greater, N+ or M+ disease at radical cystectomy. A logistic regression multivariable model was used for the risk of under staging. Overall survival was assessed using the Kaplan-Meier method. Results: Of 95 patients 26 (27%) had under staged disease. Median followup was 24 months. Compared to accurately staged cases under staged cases were more likely to have muscularis mucosae invasion (54% vs 19%, p = 0.001), mixed histology (42% vs 17%, p = 0.02) and urethral involvement (31% vs 10%, p = 0.03). In a multivariable model muscularis mucosae invasion increased the odds of under staging 9-fold (95% CI 1.5-54.5, p = 0.01). The cumulative association of these risk factors increased the odds of under staging 20-fold (95% CI 1.8-217, p = 0.0029). Median overall survival (years) was lower in patients with under staged disease (1.4 vs 10.6, p <0.001), those with muscularis mucosae invasion (2.2 vs 6.5, p = 0.04) and those with urethral involvement (25th percentile 0.8 vs 2.0, p = 0.01). Conclusions: Under staging adversely impacts survival. Muscularis mucosae invasion, urethral involvement and mixed histology cumulatively increase the risk of under staging, and may be valuable in counseling patients regarding early, aggressive intervention.

Original languageEnglish (US)
Pages (from-to)59-65
Number of pages7
JournalJournal of Urology
Volume182
Issue number1
DOIs
StatePublished - Jul 2009
Externally publishedYes

Fingerprint

Urinary Bladder Neoplasms
Mucous Membrane
Survival
Cystectomy
Histology
Biopsy
Counseling
Logistic Models
Muscles

Keywords

  • cystectomy
  • pathology
  • urinary bladder neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Multiple Adverse Histological Features Increase the Odds of Under Staging T1 Bladder Cancer. / Weizer, Alon Z.; Wasco, Matthew J.; Wang, Rou; Daignault, Stephanie; Lee, Cheryl T.; Shah, Rajal B.

In: Journal of Urology, Vol. 182, No. 1, 07.2009, p. 59-65.

Research output: Contribution to journalArticle

Weizer, Alon Z. ; Wasco, Matthew J. ; Wang, Rou ; Daignault, Stephanie ; Lee, Cheryl T. ; Shah, Rajal B. / Multiple Adverse Histological Features Increase the Odds of Under Staging T1 Bladder Cancer. In: Journal of Urology. 2009 ; Vol. 182, No. 1. pp. 59-65.
@article{49e71c671be44f51a4ecf5b529742a87,
title = "Multiple Adverse Histological Features Increase the Odds of Under Staging T1 Bladder Cancer",
abstract = "Purpose: The clinical under staging of T1 bladder cancer potentially delays therapy and undermines survival. In this study we evaluated clinicopathological features to aid in the identification of patients with clinical T1 bladder cancer at risk for under staging. Materials and Methods: We identified patients diagnosed with clinical T1 bladder cancer who underwent cystectomy within 4 months. Muscularis propria was present and uninvolved in initial biopsies or patients had a re-staging biopsy with muscle invasion present. Under staging was defined as pT2 or greater, N+ or M+ disease at radical cystectomy. A logistic regression multivariable model was used for the risk of under staging. Overall survival was assessed using the Kaplan-Meier method. Results: Of 95 patients 26 (27{\%}) had under staged disease. Median followup was 24 months. Compared to accurately staged cases under staged cases were more likely to have muscularis mucosae invasion (54{\%} vs 19{\%}, p = 0.001), mixed histology (42{\%} vs 17{\%}, p = 0.02) and urethral involvement (31{\%} vs 10{\%}, p = 0.03). In a multivariable model muscularis mucosae invasion increased the odds of under staging 9-fold (95{\%} CI 1.5-54.5, p = 0.01). The cumulative association of these risk factors increased the odds of under staging 20-fold (95{\%} CI 1.8-217, p = 0.0029). Median overall survival (years) was lower in patients with under staged disease (1.4 vs 10.6, p <0.001), those with muscularis mucosae invasion (2.2 vs 6.5, p = 0.04) and those with urethral involvement (25th percentile 0.8 vs 2.0, p = 0.01). Conclusions: Under staging adversely impacts survival. Muscularis mucosae invasion, urethral involvement and mixed histology cumulatively increase the risk of under staging, and may be valuable in counseling patients regarding early, aggressive intervention.",
keywords = "cystectomy, pathology, urinary bladder neoplasms",
author = "Weizer, {Alon Z.} and Wasco, {Matthew J.} and Rou Wang and Stephanie Daignault and Lee, {Cheryl T.} and Shah, {Rajal B.}",
year = "2009",
month = "7",
doi = "10.1016/j.juro.2009.02.116",
language = "English (US)",
volume = "182",
pages = "59--65",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Multiple Adverse Histological Features Increase the Odds of Under Staging T1 Bladder Cancer

AU - Weizer, Alon Z.

AU - Wasco, Matthew J.

AU - Wang, Rou

AU - Daignault, Stephanie

AU - Lee, Cheryl T.

AU - Shah, Rajal B.

PY - 2009/7

Y1 - 2009/7

N2 - Purpose: The clinical under staging of T1 bladder cancer potentially delays therapy and undermines survival. In this study we evaluated clinicopathological features to aid in the identification of patients with clinical T1 bladder cancer at risk for under staging. Materials and Methods: We identified patients diagnosed with clinical T1 bladder cancer who underwent cystectomy within 4 months. Muscularis propria was present and uninvolved in initial biopsies or patients had a re-staging biopsy with muscle invasion present. Under staging was defined as pT2 or greater, N+ or M+ disease at radical cystectomy. A logistic regression multivariable model was used for the risk of under staging. Overall survival was assessed using the Kaplan-Meier method. Results: Of 95 patients 26 (27%) had under staged disease. Median followup was 24 months. Compared to accurately staged cases under staged cases were more likely to have muscularis mucosae invasion (54% vs 19%, p = 0.001), mixed histology (42% vs 17%, p = 0.02) and urethral involvement (31% vs 10%, p = 0.03). In a multivariable model muscularis mucosae invasion increased the odds of under staging 9-fold (95% CI 1.5-54.5, p = 0.01). The cumulative association of these risk factors increased the odds of under staging 20-fold (95% CI 1.8-217, p = 0.0029). Median overall survival (years) was lower in patients with under staged disease (1.4 vs 10.6, p <0.001), those with muscularis mucosae invasion (2.2 vs 6.5, p = 0.04) and those with urethral involvement (25th percentile 0.8 vs 2.0, p = 0.01). Conclusions: Under staging adversely impacts survival. Muscularis mucosae invasion, urethral involvement and mixed histology cumulatively increase the risk of under staging, and may be valuable in counseling patients regarding early, aggressive intervention.

AB - Purpose: The clinical under staging of T1 bladder cancer potentially delays therapy and undermines survival. In this study we evaluated clinicopathological features to aid in the identification of patients with clinical T1 bladder cancer at risk for under staging. Materials and Methods: We identified patients diagnosed with clinical T1 bladder cancer who underwent cystectomy within 4 months. Muscularis propria was present and uninvolved in initial biopsies or patients had a re-staging biopsy with muscle invasion present. Under staging was defined as pT2 or greater, N+ or M+ disease at radical cystectomy. A logistic regression multivariable model was used for the risk of under staging. Overall survival was assessed using the Kaplan-Meier method. Results: Of 95 patients 26 (27%) had under staged disease. Median followup was 24 months. Compared to accurately staged cases under staged cases were more likely to have muscularis mucosae invasion (54% vs 19%, p = 0.001), mixed histology (42% vs 17%, p = 0.02) and urethral involvement (31% vs 10%, p = 0.03). In a multivariable model muscularis mucosae invasion increased the odds of under staging 9-fold (95% CI 1.5-54.5, p = 0.01). The cumulative association of these risk factors increased the odds of under staging 20-fold (95% CI 1.8-217, p = 0.0029). Median overall survival (years) was lower in patients with under staged disease (1.4 vs 10.6, p <0.001), those with muscularis mucosae invasion (2.2 vs 6.5, p = 0.04) and those with urethral involvement (25th percentile 0.8 vs 2.0, p = 0.01). Conclusions: Under staging adversely impacts survival. Muscularis mucosae invasion, urethral involvement and mixed histology cumulatively increase the risk of under staging, and may be valuable in counseling patients regarding early, aggressive intervention.

KW - cystectomy

KW - pathology

KW - urinary bladder neoplasms

UR - http://www.scopus.com/inward/record.url?scp=67349158889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349158889&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2009.02.116

DO - 10.1016/j.juro.2009.02.116

M3 - Article

C2 - 19447443

AN - SCOPUS:67349158889

VL - 182

SP - 59

EP - 65

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 1

ER -